Bacterial pneumonia is a type of lung infection caused by bacteria. It can affect people of any age,
but it is more common in older adults and those with weakened immune systems.
Bacterial Pneumonia
Clinical Trials
Some bacteria that cause pneumonia have become resistant to common antibiotics, so we needed new treatments that can fight these resistant bacteria. Our bacterial pneumonia study drug is a promising new medication that has shown to be effective against these resistant bacteria in lab tests and animals. We’re researching whether it can also help people with pneumonia caused by these tough-to-treat bacteria.
Current Status
Total Studies
Enrollment Process
Clinical trials are essential for advancing medical knowledge and improving patient care by testing the efficacy and safety of potential treatments before they are widely available to the public. Here’s what you can expect when considering enrollment.
Recruitment
Recruiting volunteers is the first step of an active clinical trial.
Phone Screening
You will undergo a phone screening to determine your eligibility.
Informed Consent
You must sign an ICF defining the purpose, procedure, potential risks & benefits, and your rights as participants.